Sygnature Discovery: The Creation of a High Throughput Screening(HTS) Facility

Sygnature Discovery established a fully integrated high-throughput screening (HTS) facility by combining Cenevo’s Mosaic sample management with HighRes automation and Genedata Screener. The new system enables reliable, large-scale screening to be performed in-house, improving data integrity, reducing manual errors, and accelerating early drug discovery workflows.

Download the case study to learn how Sygnature:

• Built an integrated HTS system in under 6 months.
• Screened 150K compounds in under 4 weeks.
• Reduced manual errors through automation.
• Ensured full traceability across samples and data.

Download the full case study to learn more!